πŸ‡ΊπŸ‡Έ FDA
Patent

US 6436966

Adenosine A3 receptor antagonists

expired A61KA61K31/4436A61K31/4439

Quick answer

US patent 6436966 (Adenosine A3 receptor antagonists) held by Takeda Chemical Ind., Ltd. expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Ind., Ltd.
Grant date
Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/4436, A61K31/4439, A61P, A61P11/00